Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
about
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung TransplantationAntibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosisAntibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosisImmunostimulatory properties of the emerging pathogen Stenotrophomonas maltophiliaAntibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosisStenotrophomonas maltophilia: an emerging global opportunistic pathogenIdentification of bacteria from the oral cavity and cloaca of snakes imported from Vietnam.Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosisPhenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophiliaClinical significance of microbial infection and adaptation in cystic fibrosis.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2002.Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.Update on antibiotics for infection control in cystic fibrosis.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Current dilemmas in antimicrobial therapy in cystic fibrosis.The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.Computed Tomography Findings of Community-Acquired Stenotrophomonas Maltophilia Pneumonia in an Immunocompetent Patient: A Case Report.Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosisA Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure.Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.Stenotrophomonas maltophilia: A marker of lung disease severity.Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.Microbial Interactions in the Cystic Fibrosis AirwayIdentification and management of unusual pathogens in cystic fibrosis
P2860
Q22306317-8423E4F7-4D10-4F7E-A20D-C3AC1D5E20E7Q24197517-7456F554-AD0A-4E41-8B1C-E2CC38F881F9Q24197766-716DF9BD-F8C2-4333-8D18-78FEF47EA348Q24672751-A487959E-F3A9-454B-864D-8926560FBF43Q26471114-E6E4C26E-29F9-48AB-AC7E-7D220069CF28Q26995336-F6E74A74-89BC-4500-BEBD-1CEA8C90907DQ31036673-0BB1DFDB-5D41-401D-A0AA-D1A29FA42AC8Q33310144-763A1C16-2123-4977-9548-75AC66339CC6Q33550582-83F623C5-1ED2-4A2B-A35C-DB7F78C9DE0EQ33836925-F160D9D9-3118-45B6-9AD5-6006EF70691DQ33874056-6B8D2D70-35FF-416D-B538-3663DB3D6EB2Q33950924-863FFEBD-4DDB-40D5-93C7-9BF398238B61Q34294110-ABC3DD74-E5D0-4127-9F7B-E6B920D7CFAAQ34491552-9E9812DA-4AEE-44D0-BAD5-727BEF95D654Q35055452-74237417-D553-42CF-A57B-92F2821341A1Q35094033-33658B4D-AC71-4582-8F40-77DBBC300A85Q35106279-9F2A6465-1A5F-4FBB-BD79-94AD99AB1183Q35536357-89DB0DCC-A033-4779-AE37-2368A4A2D90DQ36171630-E2C47A74-D061-4DB9-AE20-43605BF703C9Q36670892-A6B5F467-588C-4E64-A957-2844DF771664Q36771148-4C0B57B0-0E82-485B-9BA0-900343AF1267Q36980425-1562EBD0-A579-4F5C-926F-9FB169F4E66DQ37608274-AE873A8F-E3C9-45A3-8F7B-E41223FA27E7Q37866819-CD9CBD0C-72D1-45F7-BB0E-3383E87177D6Q38042719-3619B527-F4AA-4DFA-9DA9-94B545B948C3Q38453923-782581C7-266E-456C-B090-CDA8B60963B5Q40090307-A25FB6F5-C590-447A-87C6-D4B150938714Q40456919-87C7C68A-70DC-4CBD-99D4-1F35CABD91F2Q40504881-F295E996-74EC-4D06-B2AF-CA08B3BECDB6Q40964077-9A545457-AE43-486E-A8B7-5B2A34594AD0Q41909591-A2F09738-11FE-486D-BCAB-70EC8D4E235CQ42215131-7A60D9B1-BFA0-480F-80F5-3F5370B89307Q46520702-CCA7415F-2F5C-48DD-9221-903DD8B1802FQ47190939-B9BA4BB1-7A0D-4244-85F8-0D4EBF8E0407Q53297625-B928A7B4-D249-4FCA-946F-1AFDFC531C48Q57174565-AFD300CA-94AD-47D2-86CF-99896A2E3C82Q57913664-F9D4EF0F-2AB4-4DDB-8158-28BD32211CBD
P2860
Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@en
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@nl
type
label
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@en
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@nl
prefLabel
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@en
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@nl
P2093
P2860
P356
P1476
Detecting Stenotrophomonas mal ...... patients with cystic fibrosis.
@en
P2093
Gordon D Rubenfeld
Kelly Otto
Moira L Aitken
P2860
P304
P356
10.1164/RCCM.2109078
P407
P577
2002-08-01T00:00:00Z